Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
Banerjee, Sube; Hellier, J; Romer, R; Dewey, M; Knapp, Martin
; Ballard, C; Baldwin, Robert; Bentham, Peter; Fox, C.; Holmes, Clive; +15 more...Katona, Cornelius; Livingston, G.; Lawton, C; McCrae, N; Moniz-Cook, E; Murray, J; Nurock, J; Orrell, Martin; O'Brien, J; Poppe, M; Thomas, A; Walwyn, R; Wilson, K; Burns, A; and Lindesay, James
(2013)
Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
Health Technology Assessment, 17 (7).
ISSN 1366-5278
Study finds no evidence to support the use of antidepressants as a first-line treatment for people with depression in Alzheimer's disease who are referred to old-age psychiatry services, as many cases will resolve with usual care
| Item Type | Article |
|---|---|
| Departments |
Social Policy Care Policy and Evaluation Centre LSE Health |
| DOI | 10.3310/hta17070 |
| Date Deposited | 26 Apr 2013 10:16 |
| URI | https://researchonline.lse.ac.uk/id/eprint/49677 |
ORCID: https://orcid.org/0000-0003-1427-0215